- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- October 2018
- 104 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- June 2018
- 82 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- July 2021
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- August 2022
United States
From €1888EUR$1,940USD£1,617GBP
- Report
- August 2022
Global
From €769EUR$790USD£658GBP
- Report
- February 2021
Global
From €2880EUR$2,960USD£2,467GBP
- Report
- April 2022
- 40 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- October 2020
- 113 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- September 2020
- 33 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- February 2024
- 85 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- July 2023
- 85 Pages
Global
From €3500EUR$3,853USD£3,103GBP
The Conjunctivitis Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Conjunctivitis is an inflammation of the conjunctiva, the thin, transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye. Conjunctivitis drugs are used to treat the symptoms of the condition, such as redness, itching, and discharge. These drugs can be administered topically, orally, or intravenously, depending on the severity of the condition. Commonly prescribed drugs for conjunctivitis include antibiotics, antihistamines, and corticosteroids.
The Conjunctivitis Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Allergan, Bausch + Lomb, Merck, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more